2024 |
Soligenix Inc
|
Independent Director |
77.5 K |
10.7 % |
2024 |
Kura Oncology Inc
|
Independent Director |
- |
- |
2023 |
Celularity Inc - Ordinary Shares - Class A
|
Independent Director |
322.5 K |
-48.6 % |
2023 |
Kura Oncology Inc
|
Independent Director |
268.5 K |
-2.3 % |
2023 |
Soligenix Inc
|
Independent Director |
70 K |
-9.7 % |
2023 |
Calliditas Therapeutics AB - ADR
|
Independent Director |
- |
- |
2022 |
Celularity Inc - Warrants (16/07/2026)
|
Independent Director |
627.7 K |
- |
2022 |
Celularity Inc - Ordinary Shares - Class A
|
Independent Director |
627.7 K |
- |
2022 |
Kura Oncology Inc
|
Independent Director |
274.9 K |
-23.2 % |
2022 |
Soligenix Inc
|
Independent Director |
77.5 K |
0.0 % |
2022 |
Calliditas Therapeutics AB - ADR
|
Independent Director |
- |
- |
2021 |
Kura Oncology Inc
|
Independent Director |
358.1 K |
15.8 % |
2021 |
Soligenix Inc
|
Independent Director |
77.5 K |
2.5 % |
2021 |
Celularity Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2021 |
Calliditas Therapeutics AB - ADR
|
Independent Director |
- |
- |
2020 |
Kura Oncology Inc
|
Independent Director |
309.2 K |
-12.7 % |
2020 |
Soligenix Inc
|
Independent Director |
75.6 K |
52.1 % |
2020 |
Calliditas Therapeutics AB - ADR
|
Independent Director |
- |
- |
2019 |
Kura Oncology Inc
|
Independent Director |
354.3 K |
- |
2019 |
Soligenix Inc
|
Independent Director |
49.7 K |
- |
2019 |
Calliditas Therapeutics AB - ADR
|
Independent Director |
- |
- |
2018 |
Soligenix Inc
|
Independent Director |
- |
- |